[Biological pathophysiology of mood disorders special reference to the neurotransmitter receptors].
Suhara
Tetsuya
T
Fujimura
Yota
Y
D000657:Amoxapine / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008562:Membrane Glycoproteins / Q000378:metabolism / Q000502:physiology*; D026901:Membrane Transport Proteins / Q000378:metabolism / Q000502:physiology*; D019964:Mood Disorders / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism / Q000502:physiology*; D017374:Paroxetine / Q000494:pharmacology / Q000627:therapeutic use; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism / Q000502:physiology*; D017447:Receptors, Dopamine D1 / Q000378:metabolism / Q000502:physiology*; D044348:Receptors, Serotonin, 5-HT2 / Q000378:metabolism / Q000502:physiology*; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D014196:Trazodone / Q000494:pharmacology / Q000627:therapeutic use
D000657:Amoxapine; D018687:Antidepressive Agents, Second-Generation; D008024:Ligands; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D017374:Paroxetine; D044282:Receptor, Serotonin, 5-HT1A; D017447:Receptors, Dopamine D1; D044348:Receptors, Serotonin, 5-HT2; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; D014196:Trazodone; C493230:SLC6A4 protein, human